MRF Board Chair Pays It Forward with the Congressionally Directed Medical Research Program
May 10, 2023Since his initial diagnosis in December 2013, MRF Board Chair and stage 4 melanoma survivor Doug Brodman has helped others understand the value of education, research, and advocacy for the disease and the importance of developing new, more effective tr …
Early ctDNA Testing Provides Another Tool for Predicting Survival Outcomes With Tebentafusp in Metastatic Uveal Melanoma
May 9, 2023The incorporation of circulating tumor DNA (ctDNA) testing into standard practice for patients with metastatic uveal melanoma receiving tebentafusp-tebn (Kimmtrak) may provide a more accurate assessment of the agent’s efficacy compared with radiographi …
#EyeGetDilated for Melanoma Awareness Month: Karen Kaludov
May 3, 2023Guest blog by Karen Kaludov, an ocular melanoma survivor and advocate who shares her journey after her recent diagnosed in 2021: Roughly 2,000 people in the US each year are diagnosed with ocular melanoma (OM). In 2021, I became one of them. Whe …
Melanoma Awareness Month: Patrick Guddal
May 3, 2023Guest blog by Patrick Guddal, a stage 3 melanoma survivor and advocate who shares his journey after being diagnosed in 2016: In the spring of 2016, I felt a small bump on my scalp. I didn’t think much of it. I figured I scratched myself in my sleep. In …
WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaphan to Emcee Melanoma Research Foundation’s Miles for Melanoma 5K
May 2, 2023New England, MA (May 2, 2023) – The Melanoma Research Foundation (MRF) is thrilled to announce that WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaphan will be returning as the event emcee for the annual Miles for Melanoma New England 5K eve …
Recent Comments